Lisa A. Carey, MD, ScM, FASCO (IMAGE)
Caption
“When there are active immune cells circulating around a tumor, the cancer tends to be easier to treat and cure. This is important because determining immune cell activity may allow us to identify which women with HER2-positive breast cancer will do well with standard, or even minimized, therapy.”
Credit
UNC Lineberger Comprehensive Cancer Center
Usage Restrictions
None
License
Original content